NCT04591431 2023-10-03
ROME
Fondazione per la Medicina Personalizzata
Phase 2 Unknown
Clinical Trials
9 trialsNCT04355858 2022-07-26
MULAN
Fudan University
Phase 2 Unknown
NCT04212702 2021-01-12
ESR1 Mutations in Asian ER+ Metastatic Breast Cancer on Hormonal Therapy-based Treatments
National Taiwan University Hospital
Unknown
NCT02109913 2019-10-14
Analysis of Tumor Tissue and Circulating Genetic Material in the Blood to Obtain Further Insight in the Effectiveness of Everolimus When Combined With Exemestane
Amsterdam UMC, location VUmc
Phase NA Unknown
NCT00499603 2016-11-01
Paclitaxel Followed by FEC Versus Paclitaxel and RAD001 Followed by FEC In Women With Breast Cancer
M.D. Anderson Cancer Center
Phase 2 Unknown
NCT02404051 2016-06-15
FEVEX
Consorzio Oncotech
Phase 3 Unknown
NCT00466102 2012-08-30
RADAR
GBG Forschungs GmbH
Phase 2 Unknown
NCT01088893 2012-05-24
Everolimus in Breast Cancer Patients After Pre-operative Chemotherapy
Organisation for Oncology and Translational Research
Phase 2 Unknown
NCT00930475 2011-01-26
Everolimus (RAD001) and Carboplatin in Pretreated Metastatic Breast Cancer
Charite University, Berlin, Germany
Phase 1/2 Unknown